Colombian National Cancer Institute inks MoU with China's BGI Genomics to combat cancer

China-based BGI Genomics, an integral part of BGI Group, has signed a Memorandum of Understanding (MoU) with t...

October 9, 2023 | Monday | News
Promega to develop microsatellite instability companion diagnostic IVD kit in collaboration with GSK

US-headquartered Promega Corporation has announced plans to develop and commercialise a microsatellite instabi...

October 4, 2023 | Wednesday | News
New blood test could improve concussion diagnosis: Australian study

A global blood test for concussion could be a step closer after Australia's Monash University-led study discovered speci...

October 5, 2023 | Thursday | News
Singapore-based Vela Diagnostics collaborates with SRL for product distribution in Japan

Singapore-based company Vela Diagnostics has announced a research collaboration with SRL Inc, a Japanese healthcare...

October 3, 2023 | Tuesday | News
Advancing embolization with purified gelatin

What makes purified gelatin the biomaterial of choice for embolization?  Embolization, a medical procedure that in...

October 1, 2023 | Sunday | News
Australia develops first-of-its-kind tool for detection of monkey pox virus

In a collaborative study published in The Lancet Microbe, the team of scientists, led by Australia's Peter Doherty Insti...

September 27, 2023 | Wednesday | News
AstraZeneca introduces AI-based lung screening technology in Malaysia

In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, UK-based pharma firm AstraZeneca has announced its ...

September 25, 2023 | Monday | News
NURA Health Screening Centre by Fujifilm opens in Mongolia

Fujifilm Corporation has announced the upcoming opening of a new "NURA" health screening centre focusing on cancer and l...

September 18, 2023 | Monday | News
Korea develops novel DNA biosensor for early diagnosis of cervical cancer

Molybdenum disulfide (MoS2) has recently garnered attention among materials science researchers owing to its ability to ...

September 8, 2023 | Friday | News
Korea's Seegene unveils Open Innovation Programme in partnership with Springer Nature

Seegene Inc., a leading South Korean company providing a total solution for polymerase chain reaction (PCR) molecular di...

September 5, 2023 | Tuesday | News
Yourgene Health launches MagBench automated DNA extraction instrument and kit for NIPT workflows

UK-headquartered Yourgene Health plc, a leading international molecular diagnostics group, has launched the Yourgene&nbs...

September 6, 2023 | Wednesday | News
How blood-based protein biomarkers enable early detection and intervention of Alzheimer’s disease

Alzheimer's disease (AD) is a rapidly growing global public health concern, with an estimated 55 million patients worldw...

September 1, 2023 | Friday | Opinion
Singapore's INEX Innovate launches epiHERA® to detect Early Endometrial Cancer

INEX Innovate, Singapore’s pioneering Women’s Life Science Health Innovations group, has launched epiHERA&re...

August 29, 2023 | Tuesday | Company results
China-based MGI partners with Korean startup NGeneBio to advance precision medicine

MGI, a China-based company committed to building core tools and technology to lead life scienc,e and South Korea based s...

August 23, 2023 | Wednesday | News
Mirxes inks new deals to scale adoption of early cancer detection solutions in APAC

Mirxes, a Singapore headquartered RNA technology company that is making diagnostic solutions for the early detection of ...

August 22, 2023 | Tuesday | News
Korea designs non-invasive test as breakthrough in early diagnosis of bladder cancer

Bladder cancer has a five-year survival rate of over 80% when detected early, but this rate declines significantly as th...

August 18, 2023 | Friday | News
Mirxes receives US FDA’s Breakthrough Device Designation for blood-based cancer detection test

Mirxes Corporation USA, the wholly owned subsidiary of Mirxes Pte Ltd, a Singapore-headquartered RNA technolog...

August 16, 2023 | Wednesday | News
“Asia-Pacific represents a vast and relatively untapped market for Digital Pathology”

How does your innovative technology differ from traditional pathology methods? JelloX Biotech is revolutionising cancer...

August 2, 2023 | Wednesday | Opinion

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls